Innovation for Health - 14 February 2019
Global Investor Forum Contact
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare


Turning Natural Variation into Product Innovation and Sustainable Growth

Fibriant leverages its expertise in fibrinogen technology to develop innovative healthcare solutions based on specific, naturally occurring, variants of human fibrinogen. Human fibrinogen plays a pivotal role in blood clotting, tissue repair and host defense against pathogens. The company has developed a pilot manufacturing process for recombinant production of different fibrinogen variants and has demonstrated pre-clinical proof of concept for specific fibrinogen variants as topical hemostat and as anti-virulence factor in staphylococcus aureus infections. Fibriant executes a hybrid business model focused on sustainable growth and is led by a team with extensive scientific, product development and business experience.

Speaker: Jaap Koopman, Founder and CEO

Jaap Koopman has over 35 years of experience in bio-medical R & D, of which 20 years in the biotech industry. In 2004 he founded ProFibrix BV and led this company as CEO through multiple venture finance rounds. As CSO he supported the development of a dry powder fibrin sealant product to approval in US and EU and was part of the management team that led the acquisition of ProFibrix BV by The Medicine Company in August 2013. In 2015 Jaap founded Fibriant BV, that is focussed on development of a recombinant fibrinogen technology platform, and currently is the CEO of this company.
Join the VIP CEO-Investor dinner

Are you a CEO or an investor and interested to network with high level delegates during our special VIP CEO-Investor evening programme and dinner? Book your tickets now!  Register here

Join the VIP CEO-Investor dinner!
Watch our brand new teaser!

The teaser of Innovation for Health 2019 is online now, including highlights of keynote speakers, sessions and themes.
Watch the new teaser film of Innovation for Health to get an impression of what you can expect.

Like what you see? Share it via social media and get a discount of €50 on your registration fee.
Watch the teaser

Teaser Innovation for Health 2019
Selected start-up pitches

An exciting part of the programme is the yearly start-up pitch contest. Ten start-up companies will get the opportunity to pitch their company and healthcare innovation to key players and decision makers in Health & Life sciences sector on 14 February at Innovation for Health and Global Investor Forum! Find out who is selected to compete in the yearly start-up pitch contest!
Check it here!

Join the Design Expo!
Sponsors & Partners
Main partner
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Award sponsor
AXON Lawyers
Award sponsor
Vereniging Innovatieve Geneesmiddelen
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.